For providers · Clinical resource

Prospective symptom charting for PMDD before referral

By Josephine W. Hazeley, MSN, PMHNP-BC
Board-certified psychiatric mental health nurse practitioner with a perinatal & postpartum focus — nearly two decades in psychiatric nursing, including research nursing on the trial behind the first FDA-approved postpartum-depression therapy. About your clinician

Clinically reviewed by Josephine W. Hazeley, PMHNP-BC on · Last updated

The single most useful thing you can do before referring a patient for PMDD is start her on prospective daily symptom ratings, because the diagnosis cannot be confirmed without them. DSM-5-TR requires confirmation “by prospective daily ratings during at least 2 consecutive symptomatic menstrual cycles” (StatPearls), so charting begun in your office means the diagnostic clock is already running when the patient reaches psychiatric care. Retrospective report, however vivid, does not meet the standard. This guide is education for referring providers; it does not replace clinical judgment for an individual patient.

Whether you confirm the diagnosis yourself or hand it off, the charting is the same — and starting it early is what prevents a patient from losing two more months in the referral queue. This is a companion to the provider PMDD referral guide.

What tool should the patient use?

The Daily Record of Severity of Problems (DRSP). It is the validated instrument for PMDD: developed to diagnose and evaluate the disorder, with high test-retest reliability and internal consistency, and validated measures of the symptom and impairment criteria (Endicott et al.). The DRSP asks the patient to rate the DSM-5 symptom domains each day and note functional interference. Standardized scoring systems such as C-PASS then convert two or more cycles of DRSP data into a DSM-5-level diagnosis (C-PASS) — the chart is effectively the diagnostic test.

If the DRSP is not readily at hand, any structured daily log that captures the same elements — the core mood symptoms, physical symptoms, functional impairment, and cycle day — is far better than retrospective recall while you obtain the validated form.

What has to be true for the data to count?

Three things: daily, prospective, and at least two cycles.

  • Daily. Ratings are made each day, including the symptom-free days — the follicular-phase entries are not filler, they are what confirm remission between periods.
  • Prospective. Entries are made that day, in real time, not reconstructed later. Backfilled ratings reintroduce the recall bias the method exists to remove.
  • At least two cycles. The criteria require two consecutive symptomatic cycles (StatPearls); one cycle can suggest a pattern but cannot confirm it.

Cycle-day tracking should accompany the symptom ratings so the luteal and follicular phases can be read off the chart.

What does the completed chart show?

The phase pattern that drives the diagnosis. A PMDD chart shows symptoms rising in the luteal phase and returning to a symptom-free follicular baseline across both cycles. A chart with a persistently elevated baseline that merely worsens premenstrually points to premenstrual exacerbation of an underlying disorder instead — a different diagnosis with different treatment, covered in PMDD vs PME for providers. Reading the follicular days first is the fastest way to tell them apart.

How do I explain this to the patient?

Frame it as the fastest route to relief, not a delay. Patients sometimes hear “track for two months” as being put off. The accurate framing is the opposite: because the diagnosis needs two cycles regardless, starting now means the picture is ready when she is seen, and a prescriber can make a provisional diagnosis and, where appropriate, begin treatment while confirmation completes (StatPearls). The patient-facing explanation is at how PMDD is diagnosed; pointing her there can help.

Where do I send the patient next?

To psychiatric evaluation that will use the charting she has started. Mindful Counseling & Wellness provides telehealth PMDD evaluation and medication management across North Carolina, led by a PMHNP-BC with a reproductive and perinatal mental health focus.

To refer, call (919) 739-3808 or email — patient name and contact are enough, and no clinical records (and no patient health details by email) are needed. For the timing of the handoff, see when to refer a patient with PMDD, or start a referral.

Sources